歯科用骨移植代替物の世界市場：洞察、競合情勢、市場予測：2028年

世界の歯科用骨移植代替物の市場規模は、2023年から2028年の予測期間中に6.87%のCAGRで拡大すると予測されています。歯科用骨移植片の需要は、主に骨感染症や骨腫瘍などの骨疾患の発生率と、世界の歯科手術件数の増加によって後押しされています。さらに、合成代替物に対する需要の高まり、発展途上国における歯科医療ツーリズムの増加、美容手術に対する需要の高まり、製品承認数の急増、製品開発における技術革新などが、2023年から2028年までの予測期間における歯科用骨移植代替物市場の全体的な成長に寄与しています。

世界保健機関（WHO）が2022年に提供したデータによると、口腔疾患は約35億人に影響を与え、5億3,000万人以上の子供たちが2022年に世界的に乳歯のう蝕に苦しんでいます。

米国歯科医師会の報告書2019によると、2019年の米国全体でのインプラント手術の成功率は約95％から98％と報告されています。同資料によると、米国では毎年約500万件のインプラント手術が行われています。

インプラント埋入前の骨移植は、既存の顎を維持するのに役立ち、インプラント手術の成功確率を高めています。このように、世界のさまざまな地域で骨の病気や手術の有病率が増加していることから、骨移植代替物に対する需要が増加し、それによって市場全体が促進されることになります。

当レポートでは、世界の歯科用骨移植代替物市場について調査し、市場の概要とともに、タイプ別、機序別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 歯科用骨移植代替物市場レポートのイントロダクション

第2章 歯科用骨移植代替物市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 歯科用骨移植代替物市場の主要な要因分析

• 歯科用骨移植代替物市場の促進要因
• 歯科用骨移植代替物市場の抑制要因と課題
• 歯科用骨移植代替物市場の機会

第5章 歯科用骨移植代替物市場におけるポーターのファイブフォース分析

第6章 歯科用骨移植代替物市場の概要

• タイプ別
• 機序別
• エンドユーザー別
• 地域別

第7章 歯科用骨移植代替物市場における企業と製品プロファイル

• Dentsply Sirona
• Medical Device Business Services, Inc.
• Institut Straumann AG
• Medtronic
• Zimmer Biomet
• Geistlich Pharma AG
• DentiumUSA
• LifeNet Health
• Collagen Matrix Inc.
• Halma plc
• Botiss biomaterials GmbH
• Wright Medical Group N.V.
• Biogennix, LLC
• BioHorizons
• RTI Surgical
• Orthogen LLC
• OSTEOGENICS BIOMEDICAL
• Regenity
• Ultradent Products Inc
• AlloSource

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Dental Bone Graft Substitutes Market in Global (2020-2028)
• Table 3: Dental Bone Graft Substitutes Market in Global by Type (2020-2028)
• Table 4: Dental Bone Graft Substitutes Market in Global by Mechanism (2020-2028)
• Table 5: Dental Bone Graft Substitutes Market in Global by End-User (2020-2028)
• Table 6: Dental Bone Graft Substitutes Market in Global by Geography (2020-2028)
• Table 7: Dental Bone Graft Substitutes Market in North America (2020-2028)
• Table 8: Dental Bone Graft Substitutes Market in the US (2020-2028)
• Table 9: Dental Bone Graft Substitutes Market in Canada (2020-2028)
• Table 10: Dental Bone Graft Substitutes Market in Mexico (2020-2028)
• Table 11: Dental Bone Graft Substitutes Market in Europe (2020-2028)
• Table 12: Dental Bone Graft Substitutes Market in France (2020-2028)
• Table 13: Dental Bone Graft Substitutes Market in Germany (2020-2028)
• Table 14: Dental Bone Graft Substitutes Market in the United Kingdom (2020-2028)
• Table 15: Dental Bone Graft Substitutes Market in Italy (2020-2028)
• Table 16: Dental Bone Graft Substitutes Market in Spain (2020-2028)
• Table 17: Dental Bone Graft Substitutes Market in the Rest of Europe (2020-2028)
• Table 18: Dental Bone Graft Substitutes Market in Asia-Pacific (2020-2028)
• Table 19: Dental Bone Graft Substitutes Market in China (2020-2028)
• Table 20: Dental Bone Graft Substitutes Market in Japan (2020-2028)
• Table 21: Dental Bone Graft Substitutes Market in India (2020-2028)
• Table 22: Dental Bone Graft Substitutes Market in Australia (2020-2028)
• Table 23: Dental Bone Graft Substitutes Market in South Korea (2020-2028)
• Table 24: Dental Bone Graft Substitutes Market in Rest of Asia-Pacific (2020-2028)
• Table 25: Dental Bone Graft Substitutes Market in the Rest of the World (2020-2028)
• Table 26: Dental Bone Graft Substitutes Market in the Middle East (2020-2028)
• Table 27: Dental Bone Graft Substitutes Market in Africa (2020-2028)
• Table 28: Dental Bone Graft Substitutes Market in South America (2020-2028)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Dental Bone Graft Substitutes Market in Global (2020-2028)
• Figure 3: Dental Bone Graft Substitutes Market in Global by Type (2020-2028)
• Figure 4: Dental Bone Graft Substitutes Market in Global by Mechanism (2020-2028)
• Figure 5: Dental Bone Graft Substitutes Market in Global by End-User (2020-2028)
• Figure 6: Dental Bone Graft Substitutes Market in Global by Geography (2020-2028)
• Figure 7: Dental Bone Graft Substitutes Market in North America (2020-2028)
• Figure 8: Dental Bone Graft Substitutes Market in the US (2020-2028)
• Figure 9: Dental Bone Graft Substitutes Market in Canada (2020-2028)
• Figure 10: Dental Bone Graft Substitutes Market in Mexico (2020-2028)
• Figure 11: Dental Bone Graft Substitutes Market in Europe (2020-2028)
• Figure 12: Dental Bone Graft Substitutes Market in France (2020-2028)
• Figure 13: Dental Bone Graft Substitutes Market in Germany (2020-2028)
• Figure 14: Dental Bone Graft Substitutes Market in the United Kingdom (2020-2028)
• Figure 15: Dental Bone Graft Substitutes Market in Italy (2020-2028)
• Figure 16: Dental Bone Graft Substitutes Market in Spain (2020-2028)
• Figure 17: Dental Bone Graft Substitutes Market in the Rest of Europe (2020-2028)
• Figure 18: Dental Bone Graft Substitutes Market in Asia-Pacific (2020-2028)
• Figure 19: Dental Bone Graft Substitutes Market in China (2020-2028)
• Figure 20: Dental Bone Graft Substitutes Market in Japan (2020-2028)
• Figure 21: Dental Bone Graft Substitutes Market in India (2020-2028)
• Figure 22: Dental Bone Graft Substitutes Market in Australia (2020-2028)
• Figure 23: Dental Bone Graft Substitutes Market in South Korea (2020-2028)
• Figure 24: Dental Bone Graft Substitutes Market in Rest of Asia-Pacific (2020-2028)
• Figure 25: Dental Bone Graft Substitutes Market in the Rest of the World (2020-2028)
• Figure 26: Dental Bone Graft Substitutes Market in the Middle East (2020-2028)
• Figure 27: Dental Bone Graft Substitutes Market in Africa (2020-2028)
• Figure 28: Dental Bone Graft Substitutes Market in South America (2020-2028)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Dental Bone Graft Substitutes Market By Type (Xenograft, Allograft, Autograft, And Others), Mechanism (Osteoconduction, Osteoinduction, Osteogenesis, And Osteopromotion), End-Users (Hospitals, Dental Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing number of dental diseases and innovations in product development across the globe.

The global dental bone graft substitutes market is estimated to grow at a CAGR of 6.87% during the forecast period from 2023 to 2028. The demand for dental bone graft substitutes is primarily being boosted by the incidence of bone diseases such as bone infections and bone tumors and the growing number of dental surgeries worldwide. Moreover, the rising demand for synthetic substitutes, growing dental medical tourism in developing countries, increasing demand for aesthetic surgeries, surging number of product approvals, and innovation in product development among others are thereby contributed to the overall growth of the dental bone graft substitutes market during the forecast period from 2023-2028.

Dental Bone Graft Substitutes Market Dynamics:

As per the data provided by the World Health Organization (WHO) 2022, oral diseases affected nearly 3.5 billion people and over 530 million children suffered from caries of their primary teeth, in 2022, globally.

According to the American Dental Association report 2019, around 95% to 98% success rate has been reported for implant surgeries in 2019, across the United States. As per the same source, around 5 million implant procedures are performed in the US every year.

Bone grafting before implant placement helps to maintain the existing jaw and increases the chances of successful implant surgery. Thus, the increasing prevalence of bone diseases and surgeries across the different regions of the globe will increase the demand for bone graft substitutes, thereby propelling the overall market.

Further, the use of biocompatible and synthetic dental grafts is a growth-propelling factor for the market during the forecast period. Tricalcium phosphate (TCP) is mostly used as a synthetic scaffold in dentistry. It provides higher osteoconductivity as compared to allografts.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.

Therefore, the above-mentioned factors will propel the dental bone graft substitutes market during the forecast period from 2023-2028.

However, the lack of adequate reimbursement policies, risks associated with autografts and allografts, and others may restrict the growth of the overall dental bone graft substitutes market.

Dental Bone Graft Substitutes Market Segment Analysis:

Dental Bone Graft Substitutes Market By Type (Xenograft, Allograft, Autograft, and Others), Mechanism (Osteoconduction, Osteoinduction, Osteogenesis, and Osteopromotion), End-Users (Hospitals, Dental Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the dental bone graft substitutes market, the Xenograft category is expected to amass a significant revenue share in the year 2022. This can be ascribed to the advantages and applications associated with the segment. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry.

The use of xenograft tissue helps stimulate the formation of new bone tissue, resulting in a strong and stable foundation for dental implants or other restorations.

Moreover, xenograft tissue is biocompatible with human tissue, meaning that it does not trigger an immune response or other adverse reactions. The compatibility of xenograft tissue with human tissue is crucial for dental implant procedures. Additionally, xenograft tissue has been shown to have a high success rate in dental procedures, with low complication rates and excellent long-term results. The high success rate of xenograft tissue in dental procedures makes it an ideal choice for patients seeking dental implants, bone regeneration, or bone augmentation.

Xenograft tissue is a cost-effective alternative to other grafting materials, such as autografts or allografts, which are more expensive and require additional procedures for harvesting or processing. The affordability of xenograft tissue makes it an excellent choice for patients seeking dental implant procedures or other restorations.

A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, and Pepgen-P15, among others.

Further, increasing product launches, approvals, and other strategic activities will also propel the demand for xenograft in the upcoming years. For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organization (CDSCO), India.

Therefore, owing to the above-mentioned factors, the xenograft category is expected to register significant growth, thereby driving the growth of the overall dental bone graft substitutes market during the forecast period.

North America is expected to dominate the overall Dental Bone Graft Substitutes Market:

Among all the regions, North America is estimated to account for the largest share of the dental bone graft substitutes market in the year 2022. Owing to the significance of key growth factors such as increasing dental diseases, the increasing number of dental implant surgeries, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, high awareness about the biomaterial-based dental bone graft substitutes, presence of key players, increasing product development activities, and others, the market for dental bone graft substitutes is expected to witness prosperity in the region during the forecast period 2022-2028.

The Centers for Disease Control and Prevention (CDC) 2021, stated that 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth, in 2021, in the United States.

The same source in 202 data also concluded that more than 1 in 4 (26%) adults had untreated tooth decay and nearly half (46%) of all adults aged 30 years or older showed signs of gum disease and severe gum disease affected about 9% of adults in the United States, in 2020.

Further, the increasing approvals by the US FDA, increasing product launches in the market, and other strategic approvals will also impact the market of dental bone graft substitutes in the upcoming years. For instance, in August 2023, RevBio, Inc., received approval from the U.S. Food and Drug Administration to start a 20-patient clinical trial to examine the safety and efficacy of a more rapidly replaced, pH-modified porous formulation of the company's bone adhesive biomaterial called Tetranite® to immediately stabilize dental implants following tooth extractions. This new formulation has shown evidence of a more biologically active bone substitution.

Also, in January 2021, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in the United States, Canada, and several other countries.

Thus, the above-mentioned factors are likely to propel the growth of the dental bone graft substitutes market in the region during the forecast period from 2023-2028.

Dental Bone Graft Substitutes Market Key Players:

Some of the key market players operating in the dental bone graft substitutes market include: Dentsply Sirona, Medical Device Business Services, Inc., Institut Straumann AG, Medtronic, Zimmer Biomet, Geistlich Pharma AG, DentiumUSA, LifeNet Health, Collagen Matrix Inc., Halma plc, Botiss biomaterials GmbH, Wright Medical Group N.V., Biogennix, LLC, BioHorizons, RTI Surgical, Orthogen LLC, OSTEOGENICS BIOMEDICAL, Regenity, Ultradent Products Inc, AlloSource, and others.

Recent Developmental Activities in the Dental Bone Graft Substitutes Market:

• In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new Genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
• In September 2021, Neoss signed an agreement with Purgo Biologics and became a key partner and distributor of the Purgo Xenograft product range for dental implant solutions in the German, Swedish, and United Kingdom markets.
• In March 2019, BioHorizons acquired Intra-Lock to include the IntraSpin system in its portfolio for better penetration in the dental bone grafts market.

Key Takeaways from the Dental Bone Graft Substitutes Market Report Study:

• Market size analysis for current dental bone graft substitutes market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global dental bone graft substitutes market.
• Various opportunities are available for the other competitors in the dental bone graft substitutes market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current dental bone graft substitutes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for dental bone graft substitute market growth in the coming future?

Target Audience who can be benefited from this Dental Bone Graft Substitutes Market Report Study:

• Dental bone graft substitute product providers
• Research organizations and consulting companies
• Dental bone graft substitutes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in dental bone graft substitutes
• Various End-users who want to know more about the dental bone graft substitute market and the latest technological developments in the dental bone graft substitute market.

Frequently Asked Questions for the Dental Bone Graft Substitutes Market:

1. What are dental bone graft substitutes?

• A bone graft is used to fix problematic joints or damaged ones, which helps grow bone around the implant. Bone grafting is performed before dental implants to restore missing teeth. Dentistry uses bone grafts as fillers and scaffolds to facilitate bone formation and promote wound healing.

2. What is the market for global dental bone graft substitutes?

• The global dental bone graft substitutes market is estimated to grow at a CAGR of 6.87% during the forecast period from 2023 to 2028.

3. What are the drivers for the global dental bone graft substitutes market?

• The demand for dental bone graft substitutes is primarily being boosted by the increasing use of bone grafts in density and a growing number of dental implant surgeries. Further, increasing accidents, injuries, and sports injuries, a growing elderly population prone to dental diseases, increasing dental medical tourism, technological advancements in dentistry, and others thereby contributing to the overall growth of the dental bone graft substitutes market during the forecast period from 2023-2028.

4. Who are the key players operating in the global dental bone graft substitutes market?

• Some of the key market players operating in the dental bone graft substitutes market include Dentsply Sirona, Medical Device Business Services, Inc., Institut Straumann AG, Medtronic, Zimmer Biomet, Geistlich Pharma AG, DentiumUSA, LifeNet Health, Collagen Matrix Inc., Halma plc, Botiss biomaterials GmbH, Wright Medical Group N.V., Biogennix, LLC, BioHorizons, RTI Surgical, Orthogen LLC, OSTEOGENICS BIOMEDICAL, Regenity, Ultradent Products Inc, AlloSource, and others.

5. Which region has the highest share in the dental bone graft substitutes market?

• North America is expected to dominate the overall dental bone graft substitutes market during the forecast period from 2023-2028. Owing to factors such as rising increasing dental diseases, the increasing number of dental implant surgeries, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness about biomaterial-based dental bone graft substitutes among others, the North American dental bone graft substitutes market is expected to growth in coming years.

Table of Contents

1. Dental Bone Graft Substitutes Market Report Introduction

2. Dental Bone Graft Substitutes Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Dental Bone Graft Substitutes Market Key Factors Analysis

• 4.1. Dental Bone Graft Substitutes Market Drivers
  • 4.1.1. Rising cases of dental diseases
  • 4.1.2. Growing number of dental implant surgeries
  • 4.1.3. Growing dental tourism in developing countries
• 4.2. Dental Bone Graft Substitutes Market Restraints and Challenges
  • 4.2.1. Lack of Adequate Reimbursement Policies
  • 4.2.2. Risks associated with autografts and allografts
• 4.3. Dental Bone Graft Substitutes Market Opportunities
  • 4.3.1. Development of porous synthetic substitutes

5. Dental Bone Graft Substitutes Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Dental Bone Graft Substitutes Market Layout

• 6.1. By Type
  • 6.1.1. Xenograft
  • 6.1.2. Allograft
  • 6.1.3. Autograft
  • 6.1.4. Others
• 6.2. By Mechanism
  • 6.2.1. Osteoconduction
  • 6.2.2. Osteoinduction
  • 6.2.3. Osteogenesis
  • 6.2.4. Osteopromotion
• 6.3. By End-Users
  • 6.3.1. Hospitals
  • 6.3.2. Dental Clinics
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North America Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.1.1. United States Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.1.2. Canada Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.1.3. Mexico Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
  • 6.4.2. Europe Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.1. France Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.2. Germany Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.3. United Kingdom Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.4. Italy Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.5. Spain Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.2.6. Rest of Europe Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
  • 6.4.3. Asia-Pacific Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.1. China Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.2. Japan Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.3. India Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.4. Australia Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.5. South Korea Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.3.6. Rest of Asia-Pacific Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
  • 6.4.4. Rest of the World (RoW) Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.4.1. Middle East Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.4.2. Africa Dental Bone Graft Substitutes Market Size in USD million (2020-2028)
    • 6.4.4.3. South America Dental Bone Graft Substitutes Market Size in USD million (2020-2028)

7. Dental Bone Graft Substitutes Market Company and Product Profiles

• 7.1. Dentsply Sirona
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Medical Device Business Services, Inc.
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Institut Straumann AG
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Medtronic
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Zimmer Biomet
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Geistlich Pharma AG
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. DentiumUSA
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. LifeNet Health
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Collagen Matrix Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Halma plc
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Botiss biomaterials GmbH
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Wright Medical Group N.V.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Biogennix, LLC
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. BioHorizons
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. RTI Surgical
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Orthogen LLC
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. OSTEOGENICS BIOMEDICAL
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. Regenity
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Ultradent Products Inc
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. AlloSource
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us